Topiramate dosage forms and strengths: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Pratik Bahekar (talk | contribs)
nocaptcha
3,696 edits
Gerald Chi (talk | contribs)
CMEAdmin, Bureaucrats, bureaucrats, editnews, exportpages, interwiki, nocaptcha, nukepages, smwadministrator, Administrators, Widget editors
17,702 edits
mNo edit summary
Line 7: Line 7:
==Dosage Forms and Strengths==
==Dosage Forms and Strengths==


Topiramate tablets are available as debossed, coated, circular tablets in the following strengths and colors:


Tablets: 25 mg, 50 mg, 100 mg, and 200 mg
25 mg white, circular, biconvex, film-coated tablets debossed with ‘E’ on one side and ‘22’ on the other side.
In order to avoid early side-effects (e.g. cognitive dysfunction) the initial dose normally is low and increased in slow steps. The usual initial dose is 25 to 50 mg daily in 2 single doses. Recommended increments are 25 to 50mg every 1 or 2 weeks. Common doses for maintenance treatment are 100 to 200 mg daily. The highest dose possible is 1,000 mg daily in divided doses.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TOPIRAMATE (TOPIRAMATE ) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32b48ea0-a215-43b8-83b4-a5435a686d68 | publisher =  | date =  | accessdate = 6 February 2014 }}</ref>
 
50 mg light yellow colored, circular, biconvex, film-coated tablets debossed with ‘E’ on one side and ‘33’ on the other side.
 
100 mg dark yellow colored, circular, biconvex, beveled edge, film-coated tablets debossed with ‘E’ on one side and ‘23’ on the other side.  
 
200 mg pink colored, circular, biconvex, beveled edge, film-coated tablets debossed with ‘E’ on one side and ‘24’ on the other side.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TOPIRAMATE (TOPIRAMATE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32b48ea0-a215-43b8-83b4-a5435a686d68 | publisher =  | date =  | accessdate = 6 February 2014 }}</ref>


==References==
==References==

Revision as of 01:55, 9 February 2014

Topiramate
TOPIRAMATE® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Topiramate
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

Dosage Forms and Strengths

Topiramate tablets are available as debossed, coated, circular tablets in the following strengths and colors:

25 mg white, circular, biconvex, film-coated tablets debossed with ‘E’ on one side and ‘22’ on the other side.

50 mg light yellow colored, circular, biconvex, film-coated tablets debossed with ‘E’ on one side and ‘33’ on the other side.

100 mg dark yellow colored, circular, biconvex, beveled edge, film-coated tablets debossed with ‘E’ on one side and ‘23’ on the other side.

200 mg pink colored, circular, biconvex, beveled edge, film-coated tablets debossed with ‘E’ on one side and ‘24’ on the other side.[1]

References

  1. ↑ "TOPIRAMATE (TOPIRAMATE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]". Retrieved 6 February 2014.

Template:Antimigraine preparations

Retrieved from "https://www.wikidoc.org/index.php?title=Topiramate_dosage_forms_and_strengths&oldid=940565"